MAbSilico is a software editor having the vision to accelerate the development of therapeutic antibodies using deeptech-driven solutions combining Artificial Intelligence and machine learning. MAbSilico is a deeptech startup – spinoff of CNRS and INRA research team – committed to the fast discovery and development of biomarker and therapeutic antibodies for our biotech costumers.
MAbSilico provides in silico tools for mAb development; epitope mapping, off-target prediction, FTO antibody proposal and target identification based on antibodies sequences.
#insilico, #mAbcharacterization, #epitopemapping, #offtarget
Skills / Know-how:
To help the development of antibodies, four services are available:
- MAbTope : epitope mapping
- MAbTarget : target identification
- MAbCross : off-target identification
- MAbSubstitute : alternative antibody identification
Centre INRA Val de Loire, Plateforme Zénoé, 37380 Nouzilly, France
Website : https://www.mabsilico.com/